Australia's most trusted
source of pharma news
Posted 1 July 2022 AM
AstraZeneca has been hit with redundancies as the company switches up its sales engagement model to focus on a new omnichannel marketing strategy.
The company's local BioPharmaceutials Division has been restructured to meet a shift in the way business is done.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.